ArticleScientific reports2025
Enhanced classification prostate cancer based on generative adversarial networks and integrated deep learning with vision transformer models.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
By eliminating the need to alter the source images, this paper introduces a secure technique for coverless image steganography that strengthens defense against steganalysis attacks. Our method makes use of a hybrid Generative Adversarial Network (GAN) with a Support Vector Machine (SVM), which is trained and validated on a Diffusion Weighted Imaging (DWI) dataset to retain visually indistinguishable steganographic representations while increasing security. A powerful feature extraction capability of several Deep Learning Models (DLMs), EfficientNet-B4, DenseNet121, and Residual Network-18 (ResNet-18), integrated with the Vision Transformer (ViT) is performed. With the highest Peak Signal-to-Noise Ratio (PSNR) of 45.87 dB and Structural Similarity Index (SSIM) of 0.98, the ViT-GAN-SVM model exceeds other suggested models in terms of steganographic quality. Additionally, the ViT-GAN-SVM system achieves 99.78% accuracy, 99.85% sensitivity, 98.99% precision, and 99.85% F1-Score in terms of diagnostic accuracy. The ViT-GAN-SVM model performs much better than other introduced models in all diagnostic performance metrics, with increases ranging from 5.55% to 6.36%. This shows that ViT-GAN-SVM is a superior choice for medical diagnostic tasks since it can correctly identify prostate cancer on the DWI prostate cancer dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.